4.2 Article

Histoimmunogenetics Markup Language 1.0: Reporting next generation sequencing-based HLA and KIR genotyping

Journal

HUMAN IMMUNOLOGY
Volume 76, Issue 12, Pages 963-974

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.humimm.2015.08.001

Keywords

HML; NGS; HLA; KIR; MIRING; Data standards; Genotyping

Categories

Funding

  1. Office of Naval Research (ONR) [N00014-12-1-0142]
  2. National Institutes of Health (NIH) [U01AI067068]
  3. National Institute of Allergy and Infectious Disease (NIAID)
  4. National Institute of General Medical Sciences (NIGMS)
  5. [R01GM109030]

Ask authors/readers for more resources

We present an electronic format for exchanging data for HLA and KIR genotyping with extensions for next-generation sequencing (NGS). This format addresses NGS data exchange by refining the Histoimmunogenetics Markup Language (HML) to conform to the proposed Minimum Information for Reporting Immunogenomic NGS Genotyping (MIRING) reporting guidelines (miring.immunogenomics. org). Our refinements of HML include two major additions. First, NGS is supported by new XML structures to capture additional NGS data and metadata required to produce a genotyping result, including analysis-dependent (dynamic) and method-dependent (static) components. A full genotype, consensus sequence, and the surrounding metadata are included directly, while the raw sequence reads and platform documentation are externally referenced. Second, genotype ambiguity is fully represented by integrating Genotype List Strings, which use a hierarchical set of delimiters to represent allele and genotype ambiguity in a complete and accurate fashion. HML also continues to enable the transmission of legacy methods (e.g. site-specific oligonucleotide, sequence-specific priming, and Sequence Based Typing (SBT)), adding features such as allowing multiple group-specific sequencing primers, and fully leveraging techniques that combine multiple methods to obtain a single result, such as SBT integrated with NGS. (C) 2015 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available